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Abstract
Background: Young children played a major role in pneumococcal nasopharyngeal carriage, acquisition, and transmission
in the era before pneumococcal conjugate vaccine (PCV) use. Few studies document pneumococcal household dynamics in
the routine-PCV7 era.
Methods: We investigated age-specific acquisition, household introduction, carriage clearance, and intra-household
transmission in a prospective, longitudinal, observational cohort study of pneumococcal nasopharyngeal carriage in 300
American Indian households comprising 1,072 participants between March 2006 and March 2008.
Results: Pneumococcal acquisition rates were 2–6 times higher in children than adults. More household introductions of
new pneumococcal strains were attributable to children ,9 years than adults $17 years (p,0.001), and older children (2–8
years) than younger children (,2 years) (p,0.008). Compared to children ,2 years, carriage clearance was more rapid in
older children (2–4 years, HRclearance 1.53 [95% CI: 1.22, 1.91]; 5–8 years, HRclearance 1.71 [1.36, 2.15]) and adults (HRclearance
1.75 [1.16, 2.64]). Exposure to serotype-specific carriage in older children (2–8 years) most consistently increased the odds of
subsequently acquiring that serotype for other household members.
Conclusions: In this community with a high burden of pneumococcal colonization and disease and routine PCV7 use,
children (particularly older children 2–8 years) drive intra-household pneumococcal transmission: first, by acquiring,
introducing, and harboring pneumococcus within the household, and then by transmitting acquired serotypes more
efficiently than household members of other ages.
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Introduction
Pneumococcal conjugate vaccines are being introduced into
routine childhood immunization schedules around the world,
including in low-resource countries. Routine infant vaccination
with heptavalent pneumococcal conjugate vaccine (PCV7; Pre-
vnar [Pfizer]) has substantially reduced pneumococcal disease in
the United States [1–4] and Europe [5]. Still, in 2008,
approximately 514,000 children under 5 years of age died from
pneumococcal disease; over 90% of these deaths occurred in
developing countries where PCV had not yet been introduced [6].
Nasopharyngeal (NP) colonization with Streptococcus pneumoniae
plays a major epidemiologic role both as a disease precursor [7,8]
and the primary mode of horizontal transmission between
individuals [9], with the household as a primary mixing pool
[10]. Pre-PCV longitudinal NP colonization studies suggest that
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children introduce new serotypes into the household more
frequently, acquire household serotypes more often, and carry
serotypes longer than adults [10–14]. Serotype-specific NP
carriage is highly temporally clustered within households
[15,16], and household exposure increases serotype-specific
acquisition in other household members eight-fold [17]. Serotypes
also differ intrinsically by carriage duration, intra-household
transmissibility, and resistance to colonization by competing
serotypes [11,14].
Longitudinal studies of intra-household pneumococcal NP
transmission have been conducted prior to PCV7 introduction
[15,16,18] or in countries where PCV7 is not widely available
[11,17] but not in the setting of PCV use. PCV reduces vaccine-
serotype (VT) carriage in both vaccinated and unvaccinated
children [19,20] and adults [21], but high carriage prevalence or
suboptimal vaccine coverage may attenuate these indirect effects
[22]. Widespread PCV use may substantially alter pneumococcal
epidemiology within households, exerting differential effects by
vaccination status and population under evaluation.
This longitudinal study aimed to characterize pneumococcal NP
acquisition, carriage duration, and transmission in American
Indian households during the routine PCV7 era. PCV7 was first
introduced to these communities in 1997 during a group-
randomized efficacy trial [23], then included in the routine infant
immunization schedule immediately afterwards in 2000 [24].
PCV7 has virtually eliminated VT carriage [25] and dramatically
reduced VT IPD (invasive pneumococcal disease), although
residual IPD rates remain four-fold those of the general US
population [24]. Since nearly all circulating pneumococci in these
communities are now non-vaccine serotypes (NVT), we did not
expect individual child vaccination status to influence household
pneumococcal dynamics in this routine-PCV7 setting. We
hypothesized that children would serve as the major route of
pneumococcal serotype introduction into the household and the
primary source of intra-household transmission, just as in the pre-
PCV7 era. Furthermore, characterization of household transmis-
sion in this high-burden population may predict perturbations in
pneumococcal ecology likely to occur in other high-burden
populations worldwide that are introducing PCV.
Methods
Ethics Statement
The study was approved by the Navajo Nation, the White
Mountain Apache tribe and the institutional review boards of the
Johns Hopkins Bloomberg School of Public Health, the Navajo
Nation, and the Phoenix Area Indian Health Service. Written
informed consent was obtained from all adult participants and
parents or guardians of enrolled children.
Longitudinal Nasopharyngeal Colonization Study
The study protocol has been previously described [25]. Briefly,
American Indian families with at least one child ,9 years and
living on or near the Navajo or White Mountain Apache
reservations in the southwestern United States were enrolled
between March 2006 and March 2008, then visited monthly for
six months (seven total visits). Household carriage risk factors and
family composition were ascertained at enrollment; individual
carriage risk factors were collected at each visit. Pneumococcal
immunization history and records of antibiotic use, hospitaliza-
tions, and (for children ,2 years) outpatient illnesses during the
study period were collected via medical chart review. Monthly NP
specimen collection, pneumococcal isolation, and serotyping were
conducted as previously described, allowing identification of
multiple serotypes per swab when multiple morphologies were
identified on a plate [25–27]. Among isolates originally classified
as 6A, Quellung reaction [28,29] or polymerase chain reaction
[27] was used to identify serotype 6C isolates. Three isolates
originally classified as 6A were not available for retesting and were
assumed to be 6C based on the testing results of other isolates.
Definitions and Statistical Methods
Daycare attendance was defined as $4 hours per week outside
of the home with $2 members of another household. PCV7
vaccination was defined as $3 doses. 23-valent pneumococcal
polysaccharide (PS23; Pneumovax [Merck]) vaccination was
defined as any previous receipt of PS23.
A NP specimen refers to a single sample from an individual; an
isolate refers to a pneumococcal strain, specified by its serotype
identified from a swab. A carriage episode refers to the isolation of a
serotype from an individual along with as any subsequent isolation
of that same serotype at consecutive visits. Carriage episodes were
incident if preceded by $1 swab negative for that serotype and
prevalent otherwise. Serotype acquisition occurred when an isolated
serotype was immediately preceded by $1 swab negative for that
serotype. Acquisitions were individual new acquisitions if the
individual had never previously carried the serotype in the study,
and individual reacquisitions otherwise. Acquisition of a serotype
never previously observed among participating household mem-
bers was a household introduction. Household introductions were
unique if a single household member acquired the new serotype and
concurrent if simultaneously acquired by .1 member. In order to
investigate serotype-specific differences in household introduction,
unadjusted categorical binomial regression was used to analyze the
serotype-specific proportion of concurrent versus unique house-
hold introductions for the ten most-commonly-introduced sero-
types (with all other serotypes as the reference category).
Statistical Methods
To analyze carriage duration, incident carriage episodes were
aligned for survival analysis on a time metric of ‘‘days from first
observed carriage’’. Clearance was defined by two consecutive
swabs negative for a carried serotype and assumed to occur at the
midpoint between the last swab positive and the first swab negative
for that serotype. Carriage episodes concluding with a missed swab
or the last study visit were right-censored. Unadjusted median time
to clearance was calculated using survival analysis. Cox regression
with cluster robust standard errors was used to analyze the effect of
age on clearance of a carried serotype, using only the first incident
observation per individual and adjusting for time-varying
(breastfeeding, tobacco or antibiotic use, daycare attendance,
and visit month) and time-fixed (household running water, tobacco
smoke, or indoor stove; vaccination status; number of household
members [total and ,6 years]; and persons per sleeping room)
covariates. To examine whether clearance rate was affected by
serotype in children, the above Cox regression was repeated for
children ,9 years, limiting to the first acquisition of one of the five
most commonly carried serotypes. Serotype was included in the
regression as a categorical variable and its inclusion tested for
significance using a Wald test. Serotype values were carried
forward for missed visits only if isolation of that same serotype both
preceded and followed the missed visit.
Individual acquisition and household introduction rates were
compared using Poisson regression with cluster robust standard
errors. Exposure was defined as [number of swab specimens
obtained–1] for all Poisson models, since acquisition could not
occur at first visit by definition. All analyses were conducted in
Stata 12 [30].
Pneumococcal NP Dynamics in the PCV7 Era
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Multilevel analysis was used to investigate age-specific intra-
household transmission patterns for the four serotypes with the greatest
number of putative transmission events (6C, 19A, 22F, and 35B). For
each serotype, separate three-level (visit, individual, household) mixed
logistic regression models for children and adults were fitted [31,32],
specifying random intercepts for household and individual with an
independent correlation structure. Visit-level adjustment for seasonality
was performed using a truncated Fourier series [33] (including the first
two pairs of terms as independent variables).
Results
Household and individual characteristics
A total of 1072 individuals in 300 households were enrolled
in the study. Table 1 summarizes household and individual
><?show=to]characteristics. Vaccination coverage was high
(83.5%) among children ,9 years, while daycare attendance was
rare (4.7%). Of 299 households self-reporting household size, 69
(23%) had all persons $6 years enrolled, 77 (26%) were missing
one person $6 years, 55 (18%) were missing two, and 98 (33%)
were missing three or more. Enrollment was more complete
among younger children: in 210 households (70%), all children ,6
years were enrolled, in 74 (25%) one child ,6 years was not
enrolled and only 15 (5%) households had two or more children
,6 years not enrolled.
NP specimens and carriage
Of the 7504 NP specimens anticipated from the 1072
participants, 6541 (87%) were successfully collected. Most (61%)
participants provided all seven swabs, and 88% provided $5. A
Table 1. Characteristics of individuals and households enrolled in the study.
Household characteristics (n = 300) Median IQR
# of members (by interview) 6 [??5, 7]
# of reported members not enrolled in study 2 [??1, 3]
# of members under age 6 (by interview) 2 [??1, 3]
# of reported members under age 6 0 [??0, 1]
not enrolled in study
# rooms in house 6 [??4, 7]




Running water 250/299 83.6%
Toilet 245/299 81.9%
Smoker in house 78/297 26.3%
Wood-burning stove 184/298 61.7%
Individual characteristics: children (#, % of enrollees in




# % # % # % # %
Male 118 50.9% 114 51.4% 89 52.7% 321 51.5%
Breastfed during study 72 31.0% 19 8.2% 4 2.4% 95 15.2%
Daycare during studya 10 4.3% 16 6.9% 3 1.8% 29 4.7%
Otitis media during study 69 29.7% 26 11.2% 12 7.7% 108 17.3%
Antibiotics during study 75 32.3% 38 16.4% 19 11.2% 132 21.2%
PCV7 (3 doses) 192 82.8% 206 92.8% 121 72.0% 520 83.5%
Total in age category (% of all participants) 232 21.6% 222 20.7% 169 15.6% 623 58.1%
Individual characteristics: adults (#, % of enrollees in
age category) 17–39 years
c 40–64 years $65 years
All adults $17
years
# % # % # % # %
Male 84 22.2% 13 21.1% 2 22.2% 99 22.0%
Antibiotics during study 49 12.9% 10 16.4% 1 9.1% 60 13.4%
Smoked during study 56 14.8% 5 1.3% 0 0.0% 61 13.6%
Chewed tobacco during study 24 6.4% 3 0.8% 1 0.3% 28 7.4%
PS23 (any previous administration)d 18 4.8% 17 27.9% 8 72.7% 43 9.6%
Total in age category (% of all participants) 379 35.3% 61 5.7% 9 0.8% 449 42.1%
aDaycare attendance was defined as $4 hours per week outside the home with 2 or more children from other households.
bIncludes one child 10 years of age.
cIncludes two parents ,17 years.
dAn additional 4 children ,9 years of age reported receipt of PS23.
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comprehensive description of prevalence and serotype distribution
has been published [25]. Carriage prevalence was high: 35.8%
overall and 55.5% in children ,5 years.
The 2412 pneumococcal isolates represented 1655 distinct
carriage episodes; 400 (24.2%) were prevalent and 1255 (75.8%)
incident. Per-swab carriage probabilities are summarized in
Table 2. Among the 945 individuals with $5 swabs, 72% carried
pneumococcus at least once during the study. The median number
of unique serotypes carried by those with $5 swabs was 1 (IQR 0,
2), with carriage of $4 unique serotypes observed in 6.4%. Of
those with $5 swabs, 92.5% of children ,9 years carried
pneumococcus at least once, compared to 41.9% of adults $17
years (p,0.0001). On average, 3.18 different serotypes were
observed in a household over the study (SD 1.86), with carriage
observed at least once in 94% of households. Circulation of .1
serotype over the course of the study was observed in 74% of
households. Compared to households with carriage observed at
least once, households without pneumococcal isolation had fewer
self-reported members (median: 4.5 versus 6.0, Wilcoxon rank-
sum p = 0.0076) and fewer children ,6 years (median: 1 versus 2,
Wilcoxon rank-sum p = 0.0009). Of 1922 household-visits with $1
NP swab obtained from the household, the number of serotypes
detected in the household was zero at 32.1%, one at 45.4%, and
two or more at 22.5% of household visits.
Concurrent serotype-specific carriage within households was
also common: for 41.7% of isolates, $1 other household member
simultaneously carried the same serotype. Among children ,9
years, there was no difference between females and males in the
proportion of isolates concurrently carried by other household
members (42.1% of isolates from female children versus 39.4%
from males, p = 0.204). Among adults $17 years, however,
concurrent household carriage was significantly more common
among adult females than males (53.1% versus 33.3% of isolates,
p = 0.006).
Duration of carriage
Most carriage episodes (70.9%, 1170/1651) were observed at a
single visit. Four individuals ,5 years carried the same serotype at
all seven study visits (two 6C and one each 19A and 33F).
Compared to children ,2 years, older children and adults cleared
carried serotypes at a greater rate (2–4 year-olds, adjusted hazard
ratio [HR] of clearance 1.53 [95% CI: 1.22, 1.91]; 5–8 year-olds,
HR 1.71 [1.36, 2.15]; adults $17 years, HR 1.75 [1.16, 2.64]). Of
the five most-commonly carried serotypes, serotype did not
significantly affect the hazard of clearance among children ,9
years (p = 0.13) or adults $17 years (p = 0.37).
Individual acquisitions
Table 2 summarizes per-swab acquisition probabilities by age,
while Figure 1 shows the adjusted mean number of events by age.
At least one individual acquisition was observed in 66.8% (632/
945) of individuals who contributed $5 swabs and 89.3% (268/
300) of all households. After adjusting for individual and
household characteristics, the rate of individual acquisition was
3–4 times higher in children ,9 years compared to adults 17–39
years (Table 3). No significant differences were seen between adult
age groups. Month of study enrollment was significantly associated
with individual acquisition (p,0.001), with adjusted acquisition
rates twice as high in those who enrolled in September compared
to February (Figure S1). Of other risk factors, only the association
between rate of acquisition and reported number of children ,6
years in the household reached significance (incidence rate ratio
[IRR] 1.09 for each additional child ,6 years, 95% CI: 1.02,
1.16).
Household introductions
Five hundred fifty-one (551) household introductions were
observed; 78.8% (434/551) were unique and 21.2% (117/551)
were concurrent. Of the concurrent introductions, two household
members simultaneously acquired the serotype on 105 occasions,
three on 11 occasions, and four on one occasion. Of individuals
Table 2. Summary of pneumococcal acquisition events by age category.
Age category
,2 years 2–4 years 5–8 years 17–39 years 40–64 years $65 years All ages
Swabs obtained (#) 1447 1379 1035 2233 376 58 6541
Total # isolatesa (#,
per-swab probability)
835 0.577 787 0.571 502 0.486 249 0.111 36 0.096 8 0.138 2417 0.37
Individual acquisitionsa
(#,per-swab probability)
369 0.301 426 0.367 285 0.326 151 0.078 21 0.065 5 0.098 1257 0.227
New acquisitionsb (#, %
individual acquisitions)
282 76.4% 357 83.8% 229 80.4% 133 88.1% 21 100.0% 4 80.0% 1026 81.6%
Reacquisitionsb (#, %
individual acquisitions)
87 23.6% 69 16.2% 56 19.6% 18 11.9% 0 0.0% 1 20.0% 231 18.4%
Household introductionsa,c
(#,per-swab probability)




102 58.3% 165 66.3% 125 72.3% 36 51.4% 5 55.6% 1 33.3% 434 63.9%
Concurrent HH introduction
(#, % of HH introductions)
73 41.7% 84 33.7% 48 27.7% 34 48.6% 4 44.4% 2 66.7% 245 36.1%
aIncluding 73 swabs for which two serotypes were identified.
bNew acquisitions defined as acquisition of serotype not previously carried; reacquisition defined as acquisition of a previously-carried serotype.
cHousehold introductions classified as ‘‘unique’’ if the participant was the only one in the family to acquire the new serotype; ‘‘concurrent’’ if more than one individual
acquired the serotype simultaneously.
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with $5 swabs, 48.3% (457/945) had at least one household
introduction. For the ten most commonly introduced serotypes in
this study, there was no difference in the proportion of concurrent
versus unique household introductions by serotype – except for
serotype 15A, which was more commonly concurrently introduced
(44.0% of introductions, p = 0.005) than other serotypes.
In multivariable Poisson analysis, the rate of new household
introduction was 3–5 times higher in children ,9 years compared
to adults 17–39 years and varied significantly with month of study
entry (Table 3; Figure S1). No other risk factor reached statistical
significance.
In a secondary analysis allowing the effect of gender to differ
between children ,9 years and adults $17 years, adult males had
a higher rate of household introduction than adult females (IRR
1.72, 95% CI: 1.03, 2.87), while the impact of gender among
children was non-significant (IRR 1.02 for males versus females,
95% CI: 0.87, 1.19).
Intra-household transmission. Considering serotypes 6C,
19A, 35B, and 22F, exposure to carriage in a child 2–8 years was
most consistently associated with a significant increase in the odds
of other household members acquiring that serotype at the next
visit (Table 4). This association was observed for serotypes 19A and
22F considering children ,9 years as potential recipients and for
19A, 22F and 35B considering adults $17 years. Exposure to
carriage in children 2–8 years appeared to have a greater effect on
acquisition for adults than children, although wide, overlapping
confidence intervals and differences in model structure precluded
direct comparison. The only other pair to reach statistical
significance was exposure of adults $17 years to serotype 6C
carriage in children ,2 years (OR 19.55, 95% CI: 4.36, 87.69).
Discussion
This study is the largest longitudinal household analysis of
pneumococcal carriage and transmission to date and the first
conducted in the setting of routine PCV use. Concordant with pre-
PCV7 household studies, our findings support a major role for
children in pneumococcal acquisition and transmission in the
household, but we have now shown that this holds true even for
settings of PCV use and high pneumococcal transmission.
Numerous studies indicate that duration of carriage decreases
with increasing age [7,15,11,13,34]. Our findings suggest that
trend is unchanged in the presence of routine PCV use. Overall
carriage duration was generally similar to that observed in this
population prior to the PCV7 introduction [26], despite changes
in serotype distribution. These results suggest that older children
continue to serve as important reservoirs of pneumococcal carriage
Figure 1. Adjusted number of pneumococcal acquisition events, by age category. Each point represents the mean number of individual
acquisitions or household introduction for an individual in a given age category (with 95% confidence interval) over the course of the study, adjusted
by all other covariates in the Poisson models set to their means.
doi:10.1371/journal.pone.0079578.g001
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within households when PCV is routinely used. Unlike other
household studies [11,34], we did not detect a significant
difference in carriage duration by serotype. This observation
may be an artifact of our monthly sampling frame, which is biased
toward detection of serotypes with longer durations of carriage
and limited our ability to resolve finer distinctions in carriage
duration.
Children have previously been observed to be the major route
of introduction of pneumococcus into the household, both in
developing [11] and developed [14] settings. Our findings indicate
that this role continues after routine PCV use, across all of the
most commonly carried serotypes in this study. Moreover, older
children appear to play a larger role in household introductions
than children ,2 years, likely due to increased exposure in the
Table 3. Risk factors for pneumococcal acquisition (Poisson regression).
Individual acquisition Household introduction
Individual characteristics IRR [95% CI] p-value IRR [95% CI] p-value
Age (years) ,2 3.79 [2.92,4.93] ,0.001 3.47 [2.36,5.11] ,0.001
2–4 4.51 [3.47,5.88] ,0.001 5.16 [3.54,7.53] ,0.001
5–8 4.13 [3.20,5.34] ,0.001 4.89 [3.42,6.99] ,0.001
17–40 REF REF
40–65 0.79 [0.51,1.22] 0.289 0.73 [0.37,1.41] 0.343
$65 0.82 [0.31,2.12] 0.676 1.17 [0.31,4.34] 0.819
Sex (male) 1.01 [0.91,1.11] 0.889 1.07 [0.92,1.25] 0.368
During studya: Breastfed 1.07 [0.92,1.23] 0.392 1.01 [0.81,1.27] 0.926
Attended daycare 0.85 [0.70,1.03] 0.093 0.96 [0.75,1.23] 0.728
Smoked tobacco 0.78 [0.50,1.20] 0.252 0.78 [0.42,1.44] 0.43
Chewed tobacco 1.45 [0.84,2.49] 0.183 1.01 [0.39,2.66] 0.977
Vaccination statusb PCV7 (.3 doses) 0.94 [0.79,1.12] 0.493 1.1 [0.85,1.42] 0.452
PS23 (any) 1.12 [0.70,1.78] 0.636 1.17 [0.53,2.57] 0.702
Month of Study Entryc ,0.001 ,0.001
Household characteristics # children ,6 1.09 [1.02,1.16] 0.009 0.93 [0.85,1.00] 0.063
All other household covariatesd NS NS
aReported at least once during the study. Daycare defined as $4 hours/week outside of home with $2 members of other families.
bFrom chart review; all other covariates ascertained via interview.
cAll models adjusted for month of study entry as a categorical variable.
dEstimates additionally adjusted for # persons in household, crowding (number of persons per sleeping room), presence of smoker, presence of wood burning stove,
and presence of running water in house. None of the other variables examined had a significant association with either individual or household carriage.
doi:10.1371/journal.pone.0079578.t003
Table 4. Intra-household pneumococcal transmission (multilevel logistic regression.
OR for acquisition [95% CI] with p-value, by serotypeb
6C 19A 35B 22F
Recipient Exposurea OR [95% CI] p-value OR [95% CI]
p-
value OR [95% CI] p-value OR [95% CI] p-value
Child (,9 y) No HH carriage REF REF REF REF
Child (,2 y) 1.08 [0.37,3.13] 0.89 1.04 [0.34,3.15] 0.95 1.98 [0.49,8.06] 0.34 2.43 [0.71,8.25] 0.156
Child (2–8 y) 2.30 [0.90,5.86] 0.08 3.80 [1.66,8.70] 0.002 3.00 [0.93,9.65] 0.065 6.93 [2.16,22.19] 0.001
Adult ($17 y) 0.29 [0.03,2.82] 0.28 0.88 [0.13,5.86] 0.89 2.53 [0.12,51.98] 0.55 1.48 [0.24,9.11] 0.673
Adult
($17 y)
No HH carriage REF REF REF REF
Child (,2 y) 19.55 [4.36,87.69] ,0.001 5.63 [0.86,36.63] 0.071 1.72 [0.17,17.93] 0.65 5.59 [1.05,29.87] 0.044
Child (2–8 y) 3.69 [0.83,16.33] 0.085 10.36 [1.80,59.45] 0.009 43.68 [7.41,257.6] ,0.001 20.99 [4.90,89.95] ,0.001
aExposure defined as carriage of the target serotype in at least one household member in the specified age range at the previous visit.
bBoth child recipient and adult recipient models adjusted for seasonality (using the first two pairs of a truncated Fourier series), recipient characteristics (age, sex) and
household characteristics (number of children ,6 y, wood- or coal-burning indoor stove, and running water). Child recipient models also adjusted for vaccination status
(defined as at least 3 doses of PCV7), and breastfeeding status (since last visit). Low PS23 coverage in adult age groups and the rarity of serotype-specific adult-to-adult
exposure precluded the addition of PS23 vaccination status and exposure to carriage in adults $17 years to the adult model. Visits in which adults 17 years were
exposed to carriage in another adult $17 years at the previous visit were excluded from the adult model.
doi:10.1371/journal.pone.0079578.t004
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community and school. In contrast, children ,2 years were the
primary source of household introduction in a pre-PCV cohort
from the United Kingdom [35], perhaps reflecting differences in
serotype distribution or age-specific exposure and acquisition
patterns between study populations. Other household introduction
analyses have not compared children by age subgroup [11,14].
Among adults in this community, men may introduce serotypes
into the household at a higher rate than women; conversely,
women may be more involved in intra-household transmission
(given their higher rates of concurrent carriage). These findings
may reflect higher rates of community exposure in men and
effective household contact in women or a bias in the subset of
men who participated in the study compared with women.
By isolating the effect of age on transmission – independent of
age-specific carriage prevalence – multilevel analysis further
confirmed the importance of older children in pneumococcal
household dynamics, especially as transmitters to adults. Interest-
ingly, for serotype 6C, exposure to carriage in children ,2 years
was significantly associated with adult acquisition, while exposure
to carriage in older children was not. This observation may be due
to imprecision alone or a true difference in serotype-specific
transmissibility patterns. In a recent pre-PCV7 Kenyan study,
mothers and siblings of all ages transmitted to neonates with
similar efficiency [36]. While our study did not specifically
examine this pairing, exposure to carriage in children 2–8 years
here tended to be more strongly associated with acquisition in
children ,9 years than carriage in other age groups.
Our study has several limitations. Risk factor data was collected
via interview, potentially introducing reporting bias. Most
households had members who declined to participate, especially
older adults and especially men. Our analyses adjusted for
reported household composition and accounted for the number
of swabs obtained by age category. Still, we cannot exclude the
possibility that observed acquisitions may have been transmitted
from missing household members. Our inferences assume that
consecutively carried or transmitted serotypes represented the
same pneumococcal strain. Multi-locus sequence typing or whole
genome sequencing may provide stronger strain-specific inferences
than serotyping alone [11]. Although our methods were capable of
detecting multiple serotypes per swab when more than one
morphology was present, our methods were unable to evaluate the
impact of strain-strain competition within the nasopharynx. Our
analysis does not distinguish between immune-mediated clearance
and displacement of one serotype by another, two biologically
distinct processes which are likely to have differential impacts on
our observed clearance rate by age group and risk factor under
study. Even in the absence of complete displacement, if a serotype
were reduced below our threshold of detection by proliferation of a
second, co-colonizing serotype, our analysis would register
clearance of the former and an acquisition of the latter, rather
than continued co-colonization. Finally, our monthly sampling
frame limited our ability to observe events occurring on a shorter
time scale.
This study provides evidence that, in the setting of PCV,
children remain the major route of pneumococcal entry into the
household, a reservoir for maintaining carriage within households,
and both the source and recipient of the majority of intra-
household transmission. The 13-valent conjugate vaccine (Pre-
vnar13, [Pfizer]) now in routine use in the United States contains
capsular polysaccharide to serotype 6A, which will likely confer
cross-protection to serotype 6C [37,38], and 19A; 19A and 6C are
the two most frequently acquired and transmitted serotypes in this
cohort. The CDC currently recommends a single PCV13 catch-up
dose for children ages 2–5 years previously vaccinated with PCV7
[39]. Given the important role of older children in household
pneumococcal dynamics, this catch-up schedule likely accelerates
PCV indirect effects by limiting household introduction and
transmission of vaccine serotypes. Finally, while our results provide
insight into pneumococcal transmission in a high-burden popula-
tion, transmission dynamics may differ in other settings according
to risk factor distribution and prevalence of carriage. Longitudinal
household studies will continue to be an important tool, defining
pneumococcal carriage dynamics as new conjugate vaccines are
introduced around the world.
Supporting Information
Figure S1 Seasonal trends in individual acquisition (X)
and household introduction (N). Incidence rate ratios and
95% confidence intervals obtained from Poisson regression
analysis (with January as reference month of study entry).
(TIF)
Acknowledgments
The authors express their appreciation to the children and adults from the
Navajo and White Mountain Apache communities who participated
actively in the studies. We also gratefully acknowledge the dedicated efforts
of the Center for American Indian Health field staff who collected these
data over many years – particularly Stella Cly, Stevie Cosay, Virgina
Crocker, Beverly Gorman, Lora Lavender, Lori Samuel, and Roxy
Thompson – and the Indian Health Service, which provided clinic space as
well as clinical and laboratory support. We also gratefully acknowledge the
work by Jennifer Scott on preceding analyses and by Mindy Perilla on data
management, as well as the statistical guidance provided by Lawrence
Moulton.
The findings and conclusions in this paper are those of the authors and
do not necessarily reflect the views of the Indian Health Service.
Author Contributions
Conceived and designed the experiments: KLO EVM RCW LRG MS
RR. Performed the experiments: DMJ MJC. Analyzed the data: JFM.
Contributed reagents/materials/analysis tools: BB. Wrote the paper: JFM
LRG KLO.
References
1. Shah SS, Ratner AJ (2006) Trends in invasive pneumococcal disease-associated
hospitalizations. Clin Infect Dis 42(1):e1–5.
2. Lexau C, Lynfield R, Danila R, Pilishvili T, Facklam R, et al. (2005) Changing
epidemiology of invasive pneumococcal disease among older adults in the era of
pediatric pneumococcal conjugate vaccine. JAMA 294(16):2043–51.
3. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. (2010) Sustained
reductions in invasive pneumococcal disease in the era of conjugate vaccine.
J Infect Dis 201(1):32–41.
4. Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, et al. (2008)
Changing epidemiology of invasive pneumococcal disease among White
Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Clin Infect Dis 47(4):476–84.
5. Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive
pneumococcal disease and serotype distribution among Streptococcus pneumoniae
isolates in young children in Europe: impact of the 7-valent pneumococcal
conjugate vaccine and considerations for future conjugate vaccines. Int J Infect
Dis 14(3):e197–209.
6. World Health Organization (2008) Estimated Hib and pneumococcal deaths for
children under 5 years of age Available: http://www.who.int/immunization_
monitoring/burden/Pneumo_hib_estimates/en/index.html. ccessed 6 Decem-
ber 2012.
7. Gray BM, Converse GM, Dillon HC (1980) Epidemiologic studies of Streptococcus
pneumoniae in infants: acquisition, carriage, and infection during the first 24
months of life. J Infect Dis 142(6):923–33.
Pneumococcal NP Dynamics in the PCV7 Era
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e79578
8. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, et al. (1997) Relationship
between nasopharyngeal colonization and the development of otitis media in
children. J Infect Dis 175(6):1440–1445.
9. Bogaert D, Groot RD, Hermans PWM (2004) Streptococcus pneumoniae
colonisation: the key to pneumococcal disease. Lancet 4(March):144–154.
10. Leino T, Hoti F, Syrjänen R, Tanskanen A, Auranen K (2008) Clustering of
serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day
care centres. BMC Infect Dis 8:173.
11. Hill PC, Townend J, Antonio M, Akisanya B, Ebruke C, et al. (2010)
Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal
study. Clin Infect Dis 50(11):1468–76.
12. Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, et al. (2005) Antibody
responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a
longitudinal household study. J Infect Dis 192(3):387–93.
13. Melegaro A, Gay NJ, Medley GF (2004) Estimating the transmission parameters
of pneumococcal carriage in households. Epidemiol Infect 132(3):433–41.
14. Melegaro A, Choi Y, Pebody R, Gay N (2007) Pneumococcal carriage in United
Kingdom families: estimating serotype-specific transmission parameters from
longitudinal data. Am J Epidemiol 166(2):228–35.
15. Auranen K, Arjas E, Leino T, Takala AK (2000) Transmission of pneumococcal
carriage in families: a latent Markov process model for binary longitudinal data.
J Am Stat Assoc 95(452):1044.
16. Leino T, Auranen K, Jokinen J, Leinonen M, Tervonen P, et al. (2001)
Pneumococcal carriage in children during their first two years: important role of
family exposure. Pediatr Infect Dis J 20(11):1022–7.
17. Granat SM, Ollgren J, Herva E, Mia Z, Auranen K, et al. (2009)
Epidemiological evidence for serotype-independent acquired immunity to
pneumococcal carriage. J Infect Dis 200(1):99–106.
18. Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, et al. (2005) A
longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage
in a UK setting. Epidemiol Infect 133(5):891–8.
19. Millar EV, O’Brien KL, Watt JP, Bronsdon MA, Dallas J, et al. (2006) Effect of
community-wide conjugate pneumococcal vaccine use in infancy on nasopha-
ryngeal carriage through 3 years of age: a cross-sectional study in a high-risk
population. Clin Infect Dis 43(1):8–15.
20. Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, et al. (2008) Indirect effect
of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization
among unvaccinated household members. Clin Infect Dis 47(8):989–96.
21. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, et al. (2006)
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an
explanation of trends in invasive pneumococcal disease. J Infect Dis
193(11):1487–94.
22. Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, et al.
(2009) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children
who participated in a 9-valent pneumococcal conjugate vaccine trial and in their
younger siblings. Pediatr Infect Dis J 28(11):990–5.
23. O’Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, et al. (2007)
Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization
among immunized and unimmunized children in a community-randomized
trial. J Infect Dis 196(8):1211–20.
24. Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, et al. (2010)
Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine
use in an American Indian population at high risk for disease. Clin Infect Dis
50(9):1238–46.
25. Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, et al. (2012)
Impact of more than a decade of pneumococcal conjugate vaccine use on
carriage and invasive potential in Native American communities. J Infect Dis
205(2):280–8.
26. Millar EV, O’Brien KL, Zell ER, Bronsdon MA, Reid R, et al. (2009)
Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White
Mountain Apache children before the introduction of pneumococcal conjugate
vaccine. Pediatr Infect Dis J 28(8):711–6.
27. Millar EV, Pimenta FC, Roundtree A, Jackson D, Carvalho Mda G, et al. (2010)
Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C
invasive disease and carriage within Navajo and White Mountain Apache
communities. Clin Infect Dis 51(11):1258–65.
28. Mercado E, Srinivasan V, Hawkins P, Chochua S, Ochoa T, et al. (2011) First
report of Streptococcus pneumoniae serotype 6D in South America. J Clin Microbiol
49(5):2080–1.
29. Melnick N, Thompson TA, Beall BW (2010) Serotype-specific typing antisera for
pneumococcal serogroup 6 serotypes 6A, 6B, and 6C. J Clin Microbiol
48(6):2311–2.
30. StataCorp. Stata Statistical Software: Release 12. College Station, TX:
StataCorp LP, 2011.
31. Pinheiro JC, Bates DM (1995) Approximations to the log-likelihood function in
the nonlinear mixed-effects model. J Comput Graph Stat 4:12–35.
32. Pinheiro JC, Chao EC (2006) Efficient Laplacian and adaptive Gaussian
quadrature algorithms for multilevel generalized linear mixed models. J Comput
Graph Stat 15:58–81.
33. Darboe MK, Fulford AJ, Secka O, Prentice AM (2010) The dynamics of
nasopharyngeal Streptococcus pneumoniae carriage among rural Gambian mother-
infant pairs. BMC Infect Dis 10:195.
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